Sun Pharma launches FEXUCLUE (Fexuprazan) in India for treatment of Erosive Esophagitis
Under license from Korea’s Daewoong Pharmaceutical, Sun Pharma introduces FEXUCLUE, a potassium-competitive acid blocker for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sun Pharma
Sun Pharma to acquire Checkpoint Therapeutics in oncology deal
Transaction to expand Sun Pharma’s onco-derm portfolio with FDA-approved treatment for advanced cSCC
Motilal Oswal Alternates invests up to INR 460 crores for majority stake in Megafine
The Sanghvi family increases its stake in Megafine as part of the transaction
Sun Pharma amongst top 5% of global pharma companies in S&P Global Sustainability Yearbook 2025
Sun Pharma secures a spot in S&P Global’s Sustainability Yearbook 2025, reflecting its ESG commitments
Sun Pharma and Philogen complete patient enrollment for Phase III soft tissue sarcoma trial
Philogen and Sun Pharma announce the completion of patient enrollment in the Phase III FIBROSARC trial for soft tissue sarcoma,…
Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer
Aalok Shanghvi to oversee global operations, R&D, and business development at Sun Pharma
Nadda urges industry, academia collaboration to build better healthcare at Healthcare Summit at IIMA
The event featured panel discussions like “Advancing Healthcare for India @ 2047” and “Transforming Healthcare – Insights from…
Sun Pharma subsidiary Taro acquires Antibe Therapeutics
Antibe Therapeutics is a clinical-stage biotechnological company based in Ontario, Canada
Sun Pharma opens training & production centre in Jammu
As part of the programme, participants will receive 25 days of intensive training in sewing and stitching. They will also be…
Sun Pharma and Philogen sign global licensing agreement for Fibromun
Agreement focuses on global commercialisation of anti-cancer immunotherapy